NSIA Expands Healthcare Investments, Targets Wider Access to Specialist Care.

The Nigeria Sovereign Investment Authority, NSIA, is expanding its investment in Nigeria’s healthcare sector through the development of specialised medical infrastructure, capacity building and strategic partnerships aimed at improving access to quality healthcare services.

The Authority’s healthcare strategy is implemented through its wholly owned healthcare subsidiary, NSIA Advanced Medical Services Limited, MedServe, which focuses on oncology, diagnostics and other specialised medical services.

Under the leadership of the Managing Director and Chief Executive Officer of NSIA, Aminu Umar Sadiq, the healthcare investment strategy is focused not only on developing medical facilities but also on building sustainable healthcare capacity, strengthening local expertise and creating systems capable of delivering long term impact.

A major milestone in the initiative is the MedServe LUTH Cancer Centre, MLCC, in Lagos, commissioned in May 2019. The centre became the first oncology facility in Nigeria to offer 3D Conformal Radiotherapy and currently houses one of the largest concentrations of radiotherapy equipment in West Africa.

The centre played an important role during the COVID 19 pandemic by providing access to advanced cancer treatment locally at a time when international travel restrictions limited Nigerians’ ability to seek specialised medical care abroad.

Since its establishment, MLCC has delivered more than 25,000 radiotherapy sessions and 10,000 chemotherapy treatments to approximately 15,000 patients. The centre has also recorded cases of Nigerians being referred back from overseas providers due to the quality and cost effectiveness of treatment available locally.

NSIA said the availability of specialised services locally has helped reduce medical tourism and foreign exchange outflows associated with overseas treatment.

The Authority has also expanded diagnostic services through the MedServe Kano Diagnostic Centre and MedServe Umuahia Diagnostic Centre. By December 2025, more than 410,000 patients had received pathology and radiology services across the two centres.

Beyond infrastructure, NSIA, through MedServe, is developing an oncology ecosystem focused on professional training, clinical research, knowledge transfer and partnerships with international medical institutions.

MedServe has established collaborations with institutions including Memorial Sloan Kettering Cancer Center, the University of Maryland Medical Center and Bio Ventures for Global Health. The partnerships are supporting clinical research, professional development and access to innovative approaches in oncology, radiology and pathology.

The healthcare subsidiary has also participated in two global cancer trials focused on prostate and breast cancer, strengthening Nigeria’s participation in international clinical research.

Expansion Across 13 States

Building on the progress recorded so far, MedServe is expanding its healthcare footprint across 13 states, with plans to develop 13 new diagnostic centres, three additional oncology centres and three cardiac catheterisation laboratories.

The expansion will cover major urban centres, including Lagos, the Federal Capital Territory and Kaduna, as well as other states such as Oyo, Sokoto, Delta and Yobe.

The initiative is expected to bring specialised diagnostic and treatment services closer to more Nigerians while creating a broader and more geographically diversified healthcare network.

To strengthen operational sustainability, MedServe has entered into long term partnerships with global equipment manufacturers Siemens and GE covering equipment supply, maintenance, training and bulk procurement.

The expansion is also supported by up to $24.3 million in blended financing secured from the International Finance Corporation, IFC, and the International Development Association, IDA.

The financing is expected to support the expansion of healthcare infrastructure while helping to maintain affordability and attract further investment into Nigeria’s healthcare sector.

NSIA said the new centres are expected to begin commissioning from mid 2026 as part of its broader commitment to strengthening domestic healthcare capacity.

The Authority said its long term objective is to support a healthcare system that can provide world class, accessible and dignified medical services within Nigeria while reducing dependence on overseas treatment.

It added that the success of its healthcare investment would ultimately be measured not only by the number of facilities established, but also by the patients served, expertise retained, investments attracted and the overall resilience of Nigeria’s healthcare system.